| Sacituzumab govitecan in metastatic triple-negative breast cancer A Bardia, SA Hurvitz, SM Tolaney, D Loirat, K Punie, M Oliveira, A Brufsky, ... New England journal of medicine 384 (16), 1529-1541, 2021 | 845 | 2021 |
| Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer A Bardia, SM Tolaney, K Punie, D Loirat, M Oliveira, K Kalinsky, A Zelnak, ... Annals of Oncology 32 (9), 1148-1156, 2021 | 186 | 2021 |
| Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic model K Naqvi, G Garcia-Manero, S Sardesai, J Oh, CE Vigil, S Pierce, X Lei, ... Journal of Clinical Oncology 29 (16), 2240, 2011 | 175 | 2011 |
| Pexidartinib, a novel small molecule CSF-1R inhibitor in use for tenosynovial giant cell tumor: a systematic review of pre-clinical and clinical development B Benner, L Good, D Quiroga, TE Schultz, M Kassem, WE Carson, ... Drug design, development and therapy, 1693-1704, 2020 | 117 | 2020 |
| Flavonoids: New frontier for immuno-regulation and breast cancer control M Sudhakaran, S Sardesai, AI Doseff Antioxidants 8 (4), 103, 2019 | 92 | 2019 |
| Estrogen receptor beta (ERβ): a ligand activated tumor suppressor R Mal, A Magner, J David, J Datta, M Vallabhaneni, M Kassem, ... Frontiers in Oncology 10, 587386, 2020 | 78 | 2020 |
| Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors AM Quick, F Zvinovski, C Hudson, A Hundley, C Evans, A Suresh, ... Supportive Care in Cancer 28, 3669-3677, 2020 | 39 | 2020 |
| Progression-free survival for real-world use of palbociclib in hormone receptor-positive metastatic breast cancer J Wilkie, MA Schickli, MJ Berger, M Lustberg, R Reinbolt, A Noonan, ... Clinical breast cancer 20 (1), 33-40, 2020 | 33 | 2020 |
| Worry and rumination in breast cancer patients: perseveration worsens self-rated health ME Renna, M Rosie Shrout, AA Madison, M Lustberg, SP Povoski, ... Journal of behavioral medicine 44, 253-259, 2021 | 31 | 2021 |
| Abstract GS3-06: Biomarker evaluation in the phase 3 ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer SA Hurvitz, SM Tolaney, K Punie, D Loirat, M Oliveira, K Kalinsky, ... Cancer Research 81 (4_Supplement), GS3-06-GS3-06, 2021 | 31 | 2021 |
| Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapy AM Quick, F Zvinovski, C Hudson, A Hundley, C Evans, JA Stephens, ... Menopause 28 (6), 642-649, 2021 | 26 | 2021 |
| A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer S Sardesai, M Badawi, E Mrozek, E Morgan, M Phelps, J Stephens, L Wei, ... Investigational new drugs 38, 1400-1410, 2020 | 24 | 2020 |
| Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple … J O’Shaughnessy, A Brufsky, HS Rugo, SM Tolaney, K Punie, S Sardesai, ... Breast cancer research and treatment 195 (2), 127-139, 2022 | 23 | 2022 |
| Inhibiting fatty acid synthase with omeprazole to improve efficacy of neoadjuvant chemotherapy in patients with operable TNBC SD Sardesai, A Thomas, C Gallagher, F Lynce, YL Ottaviano, TJ Ballinger, ... Clinical Cancer Research 27 (21), 5810-5817, 2021 | 22 | 2021 |
| Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study E Morgan, A Suresh, A Ganju, DG Stover, R Wesolowski, S Sardesai, ... World journal of surgical oncology 18, 1-12, 2020 | 21 | 2020 |
| Genomic features of rapid versus late relapse in triple negative breast cancer Y Zhang, S Asad, Z Weber, D Tallman, W Nock, M Wyse, JF Bey, KL Dean, ... BMC cancer 21 (1), 568, 2021 | 18 | 2021 |
| Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer S Sardesai, J Sukumar, M Kassem, M Palettas, J Stephens, E Morgan, ... Cardio-Oncology 6, 1-9, 2020 | 18 | 2020 |
| TTF-1 positive primary small cell carcinoma of the breast: a case report and review of the literature H Boutrid, M Kassem, G Tozbikian, E Morgan, J White, M Shah, ... Frontiers in Endocrinology 11, 228, 2020 | 18 | 2020 |
| Physical activity after breast cancer surgery: does depression make exercise feel more effortful than it actually is? AC Padin, SJ Wilson, BE Bailey, WB Malarkey, MB Lustberg, WB Farrar, ... International journal of behavioral medicine 26, 237-246, 2019 | 16 | 2019 |
| Long-Term Follow-Up of Fractional CO2 Laser Therapy for Genitourinary Syndrome of Menopause in Breast Cancer Survivors AM Quick, A Hundley, C Evans, JA Stephens, B Ramaswamy, ... Journal of Clinical Medicine 11 (3), 774, 2022 | 15 | 2022 |
